Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the congenital heart disease (chd) market right now?

The congenital heart disease (CHD) market has grown rapidly in recent years. It is set to increase from $4.42 billion in 2024 to $4.87 billion in 2025, at a compound annual growth rate (CAGR) of 10.1%. The market’s expansion is attributed to factors such as higher prevalence of risk factors like obesity and smoking, better diagnostic technologies, an aging population, heightened awareness campaigns, improved reimbursement policies, and more investment in research and development.

How fast Is the congenital heart disease (chd) market expected to grow, and what’s its future value?

The congenital heart disease (CHD) market is projected to reach $7.05 billion by 2029, growing at a CAGR of 9.7%. Growth is driven by expanded healthcare access in developing regions, innovations in cardiac imaging, awareness campaigns for early detection, rising healthcare expenditures, and the development of personalized medicine. Key trends include minimally invasive surgery, telemedicine for remote monitoring, personalized treatments, innovative implantable devices, and AI/machine learning in diagnostics.

Get your congenital heart disease (chd) market report here!

https://www.thebusinessresearchcompany.com/report/congenital-heart-disease-chd-global-market-report

What are the leading drivers of growth in the congenital heart disease (chd) market?

The increase in maternal diabetes cases is expected to drive growth in the congenital heart disease (CHD) market. Maternal diabetes, which can lead to congenital heart defects in infants, is on the rise due to factors like sedentary lifestyles and unhealthy eating habits. The National Health Service in October 2023 reported that adverse pregnancy outcomes in women with type 2 diabetes increased from 4.9% in 2021 to 6.6% in 2022. This rise in maternal diabetes cases is fueling the growth of the CHD market.

What are the key segments defining the congenital heart disease (chd) market?

The congenital heart disease (CHD) market covered in this report is segmented –

1) By Type: Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types

2) By Diagnosis: Electrocardiogram, Chest X-ray,  Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis

3) By Treatment: Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications

4) By Age Group: Infants, Children, Adolescents, Adults

5) By Application: Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions

Subsegments:

1) By Heart Valve Defects: Aortic Valve Stenosis, Pulmonary Valve Stenosis, Mitral Valve Prolapse, Tricuspid Valve Defects, Valve Regurgitation

2) By Heart Wall Defects: Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Atrioventricular Septal Defect (AVSD), Hypoplastic Left Heart Syndrome (HLHS), Tetralogy of Fallot (TOF)

3) By Blood Vessel Defects: Coarctation Of The Aorta, Patent Ductus Arteriosus (PDA), Pulmonary Artery Stenosis, Transposition Of The Great Arteries (TGA), Truncus Arteriosus

4) By Other Types: Single Ventricle Defects, Ebstein’s Anomaly, Total Anomalous Pulmonary Venous Return (TAPVR), Coronary Artery Anomalies, Pulmonary Venous Obstruction

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15545&type=smp

Who are the key players steering the development of the congenital heart disease (chd) market?

Major companies operating in the congenital heart disease (CHD) market are Pfizer Inc., AstraZeneca Plc, Abbott Laboratories, Novartis AG, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Neusoft Corp., Carestream Health, Midmark Corporation, Contec Medical Systems, Randox Laboratories Ltd., Schiller AG, BPL Medical Technologies, Compumedics Limited, Biocare Medical, Bionet America Inc., Nasan Medical Electronics Pvt Ltd

What emerging trends are influencing the growth of the congenital heart disease (chd) market?

Companies in the congenital heart disease market are focusing on non-surgical heart valves to provide minimally invasive treatment options. Non-surgical valves offer an alternative to open-heart surgery, improving patient outcomes. For example, in February 2023, Medtronic, a US-based medical technology company, reintroduced the Harmony Transcatheter Pulmonary Valve (TPV) System. This FDA-approved valve provides a non-surgical solution for patients with severe pulmonary valve regurgitation, advancing treatment options for congenital heart disease.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15545

Which regions are most influential in expanding the congenital heart disease (chd) market?

North America was the largest region in the congenital heart disease (CHD) market in 2023. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cardiovascular Digital Solutions Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-digital-solutions-global-market-report

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Ultrasound Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-ultrasound-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: